uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 2, 2021

Seller of Aloe Products Warned for Claiming to Treat Joint Stiffness

On January 22, 2021, the FDA issued a warning letter to American Global Health Group, LLC following a review of the company's website, which found statements made about the company's products AloeCure VeraFlex, AloeCure Advanced Formula Capsule, AloeCure Pure Aloe Vera Extract, and AloeCure Probiotic + Enzyme to be drug claims.

For example, AloeCure VeraFlex was promoted with statements such as "Featuring A Clinically Proven Ingredient to Improve... Mobility, and Reduce Joint Discomfort" and "Increase mobility, reduce stiffness..."

See ConsumerLab's Aloe Liquids, Gels, and Supplements Review for tests of related products.

AloeCure Pure Aloe Vera Extract was promoted with statements such as "Aloe Extract will coat your esophagus and calm your stomach. Once it contacts excess stomach acid, this soothing extract will neutralize it instantly."

In addition, the products were found to be misbranded because they do not contain adequate directions for safe use, as required by federal regulations.

For more information, use the link below.

Warning Letter: American Global Health Group, LLC

See related warnings:

Seller of Omega-3 Warned for Making Claims to Treat Focus, Mood

Seller of Cholesterol, Weight Loss Products, and More Warned for Claims

FDA Warns Seller of Evening Primrose Oil and Beta Glucan

FDA Warns Seller of Curcumin and Cholesterol Supplements

FDA Warns Immusist for Drug Claims